Pediatrix Medical Group, Inc. $MD Shares Sold by Brant Point Investment Management LLC

Key Points

• Brant Point Investment Management LLC has reduced its holdings in Pediatrix Medical Group by 24.2%, now owning approximately 0.06% of the company, valued at $787,000.
• Several hedge funds, including California State Teachers Retirement System and AlphaQuest LLC, have adjusted their investments in Pediatrix Medical Group, reflecting a mix of increases and decreases in stakes.
• Pediatrix Medical Group recently reported $0.53 EPS for the quarter, exceeding analysts' estimates, while revenue decreased by 7.1% compared to the previous year.

Brant Point Investment Management LLC cut its stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 24.2% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 54,327 shares of the company's stock after selling 17,363 shares during the quarter. Brant Point Investment Management LLC owned about 0.06% of Pediatrix Medical Group worth $787,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. GAMMA Investing LLC increased its stake in shares of Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after acquiring an additional 1,765 shares during the last quarter. AlphaQuest LLC increased its stake in shares of Pediatrix Medical Group by 16.0% in the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock worth $85,000 after acquiring an additional 811 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Pediatrix Medical Group by 218.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after acquiring an additional 5,104 shares during the last quarter. Squarepoint Ops LLC acquired a new stake in shares of Pediatrix Medical Group in the 4th quarter worth $132,000. Finally, Sherbrooke Park Advisers LLC acquired a new stake in shares of Pediatrix Medical Group in the 4th quarter worth $136,000. 97.71% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on MD shares. Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating in a report on Monday, August 11th. Macquarie increased their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Finally, UBS Group increased their price target on Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $16.75.

Pediatrix Medical Group Stock Up 0.5%

MD stock traded up $0.08 during mid-day trading on Monday, reaching $17.18. The company had a trading volume of 710,110 shares, compared to its average volume of 956,115. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. The company has a market capitalization of $1.50 billion, a price-to-earnings ratio of 13.32 and a beta of 1.29. The firm has a fifty day simple moving average of $14.13 and a 200 day simple moving average of $14.04. Pediatrix Medical Group, Inc. has a fifty-two week low of $10.06 and a fifty-two week high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.11. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The company had revenue of $468.84 million for the quarter, compared to analyst estimates of $464.37 million. During the same quarter last year, the company earned $0.34 EPS. Pediatrix Medical Group's revenue for the quarter was down 7.1% compared to the same quarter last year. Analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.